We are live on ! Find out more
TSVT

2seventy bio

Delisted

TSVT was delisted on the 13th of May, 2025.

149 hedge funds and large institutions have $505M invested in 2seventy bio in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 61 increasing their positions, 30 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

184% more call options, than puts

Call options by funds: $1.16M | Put options by funds: $407K

103% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 30

14% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 22

2% more funds holding

Funds holding: 146149 (+3)

1% less capital invested

Capital invested by funds: $508M → $505M (-$3.26M)

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
149
Holders Change
+3
Holders Change %
+2.05%
% of All Funds
2.34%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
25
Increased
61
Reduced
30
Closed
22
Calls
$1.16M
Puts
$407K
Net Calls
+$748K
Net Calls Change
+$456K
Name Holding Trade Value Shares
Change
Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$4.63M +$1.14M +107,856 +31%
Charles Schwab
27
Charles Schwab
California
$4.23M +$1.04M +97,836 +31%
Fidelity Investments
28
Fidelity Investments
Massachusetts
$3.22M +$124K +11,673 +4%
Dimensional Fund Advisors
29
Dimensional Fund Advisors
Texas
$3.15M +$3.3M +311,246 New
BL
30
Bleichroeder LP
New York
$2.58M +$951K +89,823 +54%
TCM
31
Tang Capital Management
California
$2.53M
Rafferty Asset Management
32
Rafferty Asset Management
New York
$2.34M +$94.9K +8,967 +4%
Mirae Asset Global Investments
33
Mirae Asset Global Investments
South Korea
$2.24M +$679K +64,090 +41%
Citadel Advisors
34
Citadel Advisors
Florida
$2.07M -$22.9M -2,162,130 -91%
MCM
35
Moore Capital Management
New York
$2.02M +$2.12M +200,000 New
PAMP
36
Polar Asset Management Partners
Ontario, Canada
$2.01M +$2.1M +198,300 New
Bank of New York Mellon
37
Bank of New York Mellon
New York
$1.86M +$465K +43,917 +31%
AA
38
AlphaCentric Advisors
Puerto Rico
$1.82M -$1.3M -122,500 -40%
WAM
39
Weiss Asset Management
Massachusetts
$1.64M
Bank of America
40
Bank of America
North Carolina
$1.52M -$2.65M -249,909 -62%
Barclays
41
Barclays
United Kingdom
$1.24M -$2.87M -271,348 -69%
Two Sigma Investments
42
Two Sigma Investments
New York
$1.17M +$1.22M +115,446 New
LPC
43
Lion Point Capital
New York
$1.13M -$618K -58,333 -34%
Prudential Financial
44
Prudential Financial
New Jersey
$1.01M +$497K +46,910 +88%
Swiss National Bank
45
Swiss National Bank
Switzerland
$995K +$38.1K +3,600 +4%
JCIA
46
Jackson Creek Investment Advisors
Colorado
$991K +$56.4K +5,323 +6%
N
47
Nuveen
North Carolina
$991K +$246K +23,231 +31%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$904K -$835K -78,878 -47%
Citigroup
49
Citigroup
New York
$865K -$1.88M -177,526 -68%
UBS Group
50
UBS Group
Switzerland
$834K -$1.15M -108,344 -57%

TSVT Hedge Fund Activity: Q2 2023 in Review

149 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q2 2023, worth a combined $505M — down 0.64% from $508M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new TSVT positions and 22 closed out — a net gain of 3 holders — while 61 added to existing stakes and 30 trimmed.

The largest buyer was Avidity Partners Management, opening a new position worth an estimated $14.2M. The largest seller was Citadel Advisors, cutting an estimated $22.9M.

  • 149 institutional investors held 2seventy bio (TSVT) as of Q2 2023, up from 146 in Q1 2023.
  • Funds reported $505M of 2seventy bio stock for Q2 2023, down 0.64% quarter-over-quarter.
  • 25 funds opened new 2seventy bio positions in Q2 2023 and 22 closed out, a net change of +3 holders.
  • The largest 2seventy bio buyer in Q2 2023 was Avidity Partners Management, an estimated $14.2M added.
  • The largest 2seventy bio seller in Q2 2023 was Citadel Advisors, an estimated $22.9M sold.

Based on aggregated 13F filings for Q2 2023.